Skip to content

In the BioHarmony Drug Report Database

Efavirenz

Sustiva, Stocrin (efavirenz) is a small molecule pharmaceutical. Efavirenz was first approved as Sustiva on 1998-09-17. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections. It is known to target cytochrome P450 3A4.
Trade Name Stocrin, Sustiva
Common Name Efavirenz
Indication acquired immunodeficiency syndrome, hiv infections
Drug Class Antivirals: non-nucleoside reverse transcriptase inhibitors; benzoxazinone derivatives; Fc fusion protein
Efavirenz
Get full access now